for Journals by Title or ISSN
for Articles by Keywords
The Tan Sheet
   Journal TOC RSS feeds Export to Zotero Follow    
   Full-text available via subscription Subscription journal
     ISSN (Print) 1530-1206
     Published by Informa plc Homepage  [13 journals]
  • Batteries Not Included: P&G Plans Duracell
    • Abstract: The firm’s plan to splin off or otherwise divest Duracell raises the question of whether billion dollar brands could follow. Separately, the firm confirms that Melanie Healey, North America head of operations – previously seen as a potential candidate to succeed current CEO A.G.
      PubDate: Mon, 27 Oct 2014 00:02:33 -040
  • FDA Recalls For Oct. 15 And 22, 2014
    • Abstract: Recalls reported by FDA for OTC drugs, nutritionals and personal care products.
      PubDate: Mon, 27 Oct 2014 00:02:20 -040
  • Weekly Trademark Review Oct. 21, 2014
    • Abstract: OTC drug, personal care product and nutriotional supplement trademark filings compiled by “The Tan Sheet” from Official Gazette of the U.S. Patent and Trademark Office, Class 3 – Cosmetics and Cleaning Preps; and Class 5 – Pharmaceuticals.
      PubDate: Mon, 27 Oct 2014 00:02:10 -040
  • Industry News Roundup
    • Abstract: Mead Johnson sales climb despite slump in China; Abbott Nutritional rides “stronger footprint”; FDA sets deadline to finalize GRAS rule; general claims need specific support in U.K.; FDA warns of drug claims; YoungYou violates GMPs; FSMA meeting slated for Nov. 13; and more TiO2 settlements under Prop 65.
      PubDate: Mon, 27 Oct 2014 00:02:01 -040
  • P&G Responds To Changing Market; Streamlining “Not A Fire
           Sale” – Lafley
    • Abstract: Shareholders at P&G’s annual meeting sought insight into the firm’s plan to divest up to half of its brands over the next two years, but CEO A.G. Lafley offered no details while asserting the soundness of the strategy in terms of focusing the company and reducing costs.
      PubDate: Mon, 27 Oct 2014 00:01:47 -040
  • Consumer Health Care New Products Roundup
    • Abstract: Amazing Grass product restores pH; GoGargle takes gargling to next level; Mission introduces pre-pregnancy vitamins; First OTC PPI launches in Canada; and WellPath offers personalized supplements.
      PubDate: Mon, 27 Oct 2014 00:01:15 -040
  • Bodyarmor Rejects NAD’s ‘Upgrade’ Claim Critique
    • Abstract: Gatorade sports drinks Stokely-Van Camp challenged that Bodyarmor Nutrition was noncompliant with NAD’s April 2014 finding that its ads combined claims that are supported individually in such a way that they created unsupported comparative claims
      PubDate: Mon, 27 Oct 2014 00:01:07 -040
  • What Not To Do When An FDA Inspector Knocks At Your Door
    • Abstract: FDA tweaks its guidance on what constitutes interference with inspections to include examples of “reasonable” explanations for delays. But industry requested other changes, including a formal process for notifying a firm of FDA’s intent to deem products adulterated due to delaying, limiting or refusing an inspection.
      PubDate: Mon, 27 Oct 2014 00:00:31 -040
  • Valeant On Stronger Ground As It Readies For Allergan Showdown
    • Abstract: The Canadian pharma reported a strong third quarter and an improved debt position as it prepares for the December meeting with Allergan shareholders that could result in changes to the Botox maker’s board and acceptance of Valeant’s takeover offer.
      PubDate: Mon, 27 Oct 2014 00:00:23 -040
  • E-Cigarettes Spark Evolution Of FDA’s Nicotine-Containing Medical
           Product Regulation
    • Abstract: FDA’s tobacco, drug and medical device centers are discussing “some sort of jurisdictional policy” to “determine how to evolve the regulation of therapeutic nicotine products,” including OTC drugs, says tobacco program head Mitch Zeller.
      PubDate: Fri, 24 Oct 2014 00:05:03 -040
  • Enforcement News Roundup
    • Abstract: FSMA meeting slated for Nov. 13; FDA warns of Bethel Nutritional drug claims and YoungYou GMPs.
      PubDate: Fri, 24 Oct 2014 00:00:07 -040
  • Ensuring GSK Consumer Products Take Leading Position Touted In Management
    • Abstract: GlaxoSmithKline restructures its management to ensure adequate focus on its three core areas, pharmaceutical, vaccine and consumer. Consumer product sales fell 3% to $1.72 billion in the third quarter due to continuing supply interruptions and generally weaker markets.
      PubDate: Thu, 23 Oct 2014 00:05:01 -040
  • NPA Sees Broad Impact While DoJ Argues Narrow Path On FTC’s Bayer
    • Abstract: “We’re worried about this sort of thinking across a broad swath of claims,” NPA chief Daniel Fabricant says of FTC’s request that Bayer support Phillips’ Colon Health claims with clinical trials. DoJ counters it “is not trying to change the way an entire industry works.”
      PubDate: Thu, 23 Oct 2014 00:00:06 -040
  • Drug-Tainted Supplements Linger On Market After Recalls – Study
    • Abstract: Researchers and industry leaders agree increased enforcement is needed against drug-tainted supplements remaining available after recalls, but not on whether regulatory changes are needed to tackle the problem. A JAMA study found 6.5% of the recalled products lingered on store shelves for at least six months.
      PubDate: Wed, 22 Oct 2014 00:05:04 -040
  • RB Consumer Provides Bright Spot In Dim Quarter Despite Slower Sales
    • Abstract: RB missed analysts third-quarter expectations by 1%, reporting a 2% sales increase to $3.82 billion. Consumer health product sales led the way with a 6% increase to $1.21 billion, dragged down slightly by slower than expected uptake of Mucinex and MegaRed products.
      PubDate: Wed, 22 Oct 2014 00:00:03 -040
  • Weight Loss Claims Land Firms On FTC Radar In First ‘Negative
           Option’ Case
    • Abstract: FTC says Health Formulas LLC of Las Vegas, and its associated firms in Nevada and California, make unsubstantiated claims for green coffee bean extract and other supplement products. A judge issued a temporary injunction against the firms from using “free” trial offers and deceptive health claims.
      PubDate: Tue, 21 Oct 2014 00:05:00 -040
  • Consumer Health Care Industry News Roundup
    • Abstract: Bodyarmor Stands By ‘Upgrade’ Claim; and More TiO2 Settlements Under Prop 65.
      PubDate: Tue, 21 Oct 2014 00:00:05 -040
  • Deception Alleged In P&G, Unilever Personal Care Product Packaging
    • Abstract: The firms have no lawful justification for the nonfunctional slack fill in their antiperspirant and deodorant packaging, which misleads consumers into paying premium prices, according to proposed class-action complaints filed in September in New York district courts.
      PubDate: Mon, 20 Oct 2014 00:01:16 -040
  • CSPI Litigation Again Targets Bayer One A Day Claims
    • Abstract: The proposed class-action complaint CSPI filed federal court marks the consumer advocacy group’s third allegation against claims for One A Day products. The complaint seeks an injunction against some claims and refunds to consumers who “purchased the products expecting the promised benefits,” CSPI says.
      PubDate: Mon, 20 Oct 2014 00:01:04 -040
  • NAD Advises Disclosures For Native Advertising Ahead Of FTC Guidance
    • Abstract: Ads designed to blend in with the platform where it appears can mislead consumers that the material is news content. Firms employing native advertising or sponsored content marketing should disclose their affiliation with external websites or links until FTC releases guidance, attorneys and NAD staffers say.
      PubDate: Mon, 20 Oct 2014 00:00:25 -040
  • Nutraceutical Sales Growth Rides On Heart, Children’s, Aging
    • Abstract: Products focused on hearth health, children’s development and aging will drive nutraceutical market growth at 7% compounded annual rate to $211 billion by 2018, Frost & Sullivan analysts say. Firms need to educate consumers about nutrition’s role in health and lower prices to expand the customer base.
      PubDate: Mon, 20 Oct 2014 00:00:20 -040
  • Mucinex Ads Cast Consumers As Heroes Fighting
           ‘Mr. Mucus’
    • Abstract: RB revamps advertising for Mucinex for the first time in 10 years to encourage consumers to kick butt during the cold and flu season. The new campaign still includes the green ne'er-do-well “Mr.
      PubDate: Fri, 17 Oct 2014 00:05:00 -040
  • DSHEA Sheds Little Light On Distinguishing Old From New Ingredients
    • Abstract: Former Senate staffer Patricia Knight, who helped write DSHEA, says her “one regret” about the act passed in 1994 is “something we left out, how to prove, how to lock in what was on the market.” There is just no way for the FDA to figure out what was on the market then,” she says.
      PubDate: Thu, 16 Oct 2014 00:05:02 -040
  • Industry News Roundup
    • Abstract: Nexium 24HR Sample Pack Approved; Boots Protection Claims Imply Prevention; Support of Philosophy serum is “inherently arbitrary,” NAD said; Nestle Formula Comparative Claims Apply Across Entire Category; Happy consumers OK for U.K. e-cig ads; Manzo Scouts Probiotic Path At FDA and Ingredion acquires Penford.
      PubDate: Thu, 16 Oct 2014 00:00:00 -040
  • J&J Consumer Sales Slip Even As Recalled Brands, Seasonal Products
           Reach Stores
    • Abstract: J&J reports worldwide consumer sales fell 0.6% to $3.6 billion despite retailers buying more upper respiratory and analgesic products to prepare for the cough and cold season. But in key OTC categories the firm is regaining marketing share it lost when its iconic brands were temporarily not available.
      PubDate: Wed, 15 Oct 2014 00:05:01 -040
School of Mathematical and Computer Sciences
Heriot-Watt University
Edinburgh, EH14 4AS, UK
Tel: +00 44 (0)131 4513762
Fax: +00 44 (0)131 4513327
About JournalTOCs
News (blog, publications)
JournalTOCs on Twitter   JournalTOCs on Facebook

JournalTOCs © 2009-2014